TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A post hoc analysis of a randomized trial found that older adults assigned to eat walnuts daily had about 6% higher total serum IgG after two years than controls. The study did not show that walnuts improved health or reduced cardiovascular risk, and it found no significant effects on several other measured immune markers.
A secondary analysis of the two-year Walnuts and Healthy Aging (WAHA) randomized trial, published in JACC Advances, found that older adults assigned to eat walnuts daily had about 6% higher total serum IgG than participants in the control group. The finding concerns an immune-system biomarker; the researchers did not establish that the change improves health or lowers cardiovascular risk.
According to the WAHA trial report, the study enrolled 708 cognitively healthy adults aged 63 to 79 in the United States and Spain. Participants were assigned either to include 30–60 grams of walnuts daily, or to follow a diet that excluded walnuts, for two years. The walnut portion represented about 15% of daily energy intake.
For the secondary analysis reported in JACC Advances, researchers measured blood samples from 474 participants at the start and after two years. They assessed total IgG and IgM, antibodies targeting malondialdehyde-modified LDL (MDA-LDL), and circulating MDA-LDL. The report says the overall IgG difference was adjusted for baseline levels and other factors. It also reports an 11% higher IgG level in the walnut group among US participants, but no statistically significant intervention effect in Spain.
The JACC Advances analysis found no significant walnut-related change in total IgM, MDA-LDL concentrations, or the measured MDA-LDL-specific IgG and IgM antibodies. Total IgG and IgM, as well as MDA-LDL-specific IgM antibodies, declined over time in both groups. The authors describe this as a post hoc analysis of the original trial, which had focused on cognition and retinal health rather than these immune markers.
What the IgG Finding Can Tell Us
IgG is a major class of antibody, and total serum IgG is one measure of the body’s circulating humoral immune response. A difference in this measure may be useful for researchers investigating whether diet is associated with immune biomarkers as people age. But a higher total IgG level is not, by itself, proof of better immunity or a health benefit. The WAHA analysis did not test whether participants had fewer infections, improved immune function, or better cardiovascular outcomes as a result of the change.
The cardiovascular connection is also indirect. Atherosclerosis involves plaque in blood vessels and inflammatory processes, while MDA-LDL can form modified particles that prompt immune responses. Earlier research has linked some antibody patterns with cardiovascular measures, but results for MDA-LDL-specific IgG have been inconsistent. In the WAHA analysis, walnuts did not significantly alter those specific antibodies or circulating MDA-LDL. The observed IgG difference therefore needs follow-up before it can be given a clinical interpretation.
Products Worth Considering
TheraGun Therabody PRO Plus 6-in-1 Deep Tissue Massage Gun, Black
Oura Ring 4 Smart Ring – Silver – Size 8
Fitbit Versa 2 Health and Fitness Smartwatch with Heart Rate, Alexa, Music, Sleep and Swim Tracking
As an affiliate, we earn on qualifying purchases.
How the WAHA Analysis Was Done
The WAHA trial report states that participants were recruited between May 2012 and May 2014. People who already ate more than two servings of tree nuts each week were excluded, as were some people using supplements such as fish oil or flaxseed oil. According to the report, participants were followed every two months for checks on weight, diet tolerance, adherence, and medication use.
This JACC Advances report describes a post hoc analysis—a later examination of blood biomarkers from the trial, not the original primary purpose of the study. The researchers estimated adherence among Spanish participants by measuring alpha-linolenic acid in red blood cell membranes; the report says levels rose in the walnut group and fell in controls. The analysis also found substantial differences in baseline immunoglobulin levels between the US and Spanish groups, and the IgG result was not statistically significant in Spain. Those differences make it difficult to assume the same association would appear in every population.
What the Biomarker Does Not Show
The authors of the JACC Advances analysis do not explain why total IgG was higher in the walnut group overall, why the result differed by country, or whether the measured difference has any meaningful effect on health. The study does not show that walnuts prevent infection, change the course of immune aging, or reduce heart disease. The original trial was not designed around these immune outcomes, and the analysis measured biomarkers rather than clinical events.
The source report describes the clinical implications as uncertain. It does not provide evidence that people should use IgG levels to decide whether to eat walnuts, nor does it establish an ideal intake for immune health. The results apply to the older adults studied and may not extend to other ages, dietary patterns, or health conditions.
What Future Research Needs to Test
Further studies would need to see whether the IgG association can be replicated in other groups and whether it corresponds to measurable health outcomes. Researchers could also investigate why the finding appeared in the combined analysis and among US participants but not in the Spanish group. Longer or specifically designed trials would be needed to test links with infections, cardiovascular events, or other clinical measures.
For now, the WAHA analysis adds a diet-and-biomarker observation, not a treatment recommendation. The JACC Advances report does not announce a planned follow-up study or give a timetable for additional results. People considering dietary changes for a medical reason should discuss them with a qualified health professional.
Key Questions
What did the walnut study find?
In the post hoc analysis of the WAHA trial published in JACC Advances, participants assigned to eat walnuts daily had about 6% higher total serum IgG than controls across the US and Spanish study centers after two years. The analysis did not find significant effects on several other measured immune markers.
Does higher IgG mean the participants were healthier?
Not necessarily. IgG is an antibody measure, but the WAHA analysis did not establish that the higher level improved immune function, prevented illness, or reduced cardiovascular risk.
How many walnuts did participants eat?
The WAHA trial assigned the intervention group 30–60 grams per day for two years, equivalent to about 15% of daily energy intake in the study.
Did walnuts change antibodies linked to artery disease?
The JACC Advances analysis found no significant walnut-related effects on antibodies targeting MDA-LDL or on circulating MDA-LDL concentrations. The clinical meaning of the total IgG result remains uncertain.
Can the results be applied to everyone?
The WAHA participants were cognitively healthy adults aged 63 to 79 in the United States and Spain. The findings do not establish that the same association applies to younger people or other populations.
Source: news-medical.net
